�� Feature Channel: Diabetes

Voce tem hipotiroidismo? Especialista explica o diagnostico e o que isso significa

Mayo Clinic — Thu, 24 Apr 2025 10:45:56 EST

JACKSONVILLE, Florida -- Voce tem se sentido cansado e ganhou peso. Pode ser apenas um sinal de que voce esta envelhecendo, mas pode haver uma chance de que esses sintomas gerais sejam causados pelo hipotiroidismo. O Dr. Victor Bernet, endocrinologista na Mayo Clinic, explica os fatores de risco e como essa condicao e diagnosticada e tratada.

Do You Have Hypothyroidism? Expert Explains Diagnosis, What It Means

Mayo Clinic — Thu, 24 Apr 2025 10:30:23 EST

JACKSONVILLE, Florida -- You've been feeling fatigued and have gained some weight. It could be just a sign that you're getting older, but these symptoms might be caused by hypothyroidism. Victor Bernet, M.D., an endocrinologist at Mayo Clinic, explains risk factors and how the condition is diagnosed and treated.

?Tiene hipotiroidismo? Experto explica el diagnostico y lo que significa

Mayo Clinic — Thu, 24 Apr 2025 09:45:07 EST

JACKSONVILLE, Florida -- Usted se ha estado sintiendo cansado y ha ganado peso. Puede ser solo una senal de que esta envejeciendo, pero puede haber una posibilidad de que estos sintomas generales sean causados por hipotiroidismo. El Dr. Victor Bernet, endocrinologo en Mayo Clinic, explica los factores de riesgo y como se diagnostica y trata esta afeccion.

هل أنت مصاب بقصور الدرقية؟ يشرح الخبراء التشخيص وما يعنيه

Mayo Clinic — Thu, 24 Apr 2025 00:05:31 EST

جاكسونفيل، ولاية فلوريدا --منذ فترة وأنت تشعر بالتعب كما أنك اكتسبت بعض الوزن. قد يكون ذلك مجرد علامة على أنك تتقدم بالعمر، ولكن هناك احتمال أن يكون سبب هذه الأعراض العامة هو قصور الدرقية. يشرح فيكتور بيرنت، دكتور في الطب اختصاصي الغدد الصماء في مايو كلينك عوامل الخطورة وكيفية تشخيص الحالة وعلاجها.

Online Tool Tests How Taxes Affect Sugar-Sweetened Drink Purchases

Virginia Tech — Wed, 23 Apr 2025 18:45:17 EST

Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC created the Experimental Beverage Marketplace to test the potential effects of these tax proposals on purchasing and consumption. Its purpose is to ensure that policy is guided by evidence.

Nudge Boosts Statin-Prescribing, Means Fewer Pharmacy Trips

Perelman School of Medicine at the University of Pennsylvania — Tue, 22 Apr 2025 19:55:56 EST

Statins are lifesaving to those with high cholesterol, but patients don't always take them. A nudge that increased long-term prescriptions could be key

Medicaid Enrollees with Diabetes Lack Access to Medications with Cardiovascular Health Benefits

American College of Physicians (ACP) — Mon, 21 Apr 2025 17:00:00 EST

A national cross-sectional study evaluated the unrestricted availability of sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the only two diabetes medications that reduce cardiovascular disease (CVD) and death, among Medicaid enrollees.

Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome

Monell Chemical Senses Center — Thu, 17 Apr 2025 20:45:00 EST

Monell Center investigators identified that GLP-1R agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. They used a genetically engineered mouse model of BBS that displayed the hallmark features of the condition.

Studying Interventions to Help Type 2 Diabetes Patients Avoid Hospitalizations

Michigan Medicine - University of Michigan — Tue, 15 Apr 2025 19:30:40 EST

Social determinants of health can have a large impact on the health of people living with type 2 diabetes

More Adults Now Use Tirzepatide and Semaglutide Over Conventional Glucose and Weight Lowering Medications

American College of Physicians (ACP) — Mon, 14 Apr 2025 17:00:00 EST

A population-based cohort study measured trends in use of tirzepatide versus other glucose-lowering medications (GLMs) and weight-lowering medications (WLMs) after tirzepatide's FDA approval.

Neonatal Diabetes Model Provides Insights on How Condition Develops

UT Southwestern Medical Center — Tue, 08 Apr 2025 19:10:06 EST

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.

Einstein Research Leads to Designation of New Type of Diabetes

Albert Einstein College of Medicine — Tue, 08 Apr 2025 15:00:39 EST

Malnutrition-related diabetes--typically affecting lean, malnourished teens and young adults in low- and middle-income countries--is now officially recognized as a distinct form of the disease, known as type 5 diabetes.

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Sbarro Health Research Organization (SHRO) — Mon, 07 Apr 2025 14:45:45 EST

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Switching to Tirzepatide Rather Than Increasing Dulaglutide Dose Leads to Better Glucose Control and More Weight Loss in Patients with Inadequately Controlled Diabetes

American College of Physicians (ACP) — Fri, 04 Apr 2025 10:00:00 EST

For patients with inadequately controlled type 2 diabetes, switching to tirzepatide improves glucose control and increases weight loss more so than maximizing dulaglutide dose.

ACP and Annals of Internal Medicine Present Breaking Scientific �� at ACP's Internal Medicine Meeting 2025

American College of Physicians (ACP) — Fri, 04 Apr 2025 10:00:00 EST

Today at the American College of Physicians (ACP) annual meeting, Internal Medicine Meeting 2025, in New Orleans, Annals of Internal Medicine presented three breaking scientific research articles during a live plenary session featuring the authors of those articles.

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

American Physiological Society (APS) — Thu, 03 Apr 2025 07:00:32 EST

Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB's 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society's (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS' flagship annual meeting, will be held April 24-27 in Baltimore.

Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry

Hackensack Meridian Pascack Valley Medical Center — Tue, 01 Apr 2025 09:00:38 EST

We're pleased to announce Carolyn Mudry, D.O, has joined the Pascack Valley Medical Group family. With over 25 years of experience, Dr. Mudry brings a wealth of expertise in providing comprehensive, patient-centered care to the patients of Pascack Valley.

Antibiotics Exposure in Infancy May Boost Diabetes Risk

University of Colorado Boulder — Mon, 31 Mar 2025 17:55:26 EST

Exposure to antibiotics during infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life. The findings shine a light on the importance of the infant microbiome and could lead to new approaches for addressing metabolic diseases.

Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit

American College of Physicians (ACP) — Mon, 31 Mar 2025 17:00:00 EST

Obesity is a leading cause of morbidity and mortality with wide-ranging health consequences that cross-cut many medical specialties.

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

American College of Physicians (ACP) — Mon, 31 Mar 2025 17:00:00 EST

An analysis of nationally representative survey data examined trends in glucagon-like peptide-1 receptor agonist (GLP-1RA) use and expenditure among people in the United States without diabetes.

�������� Feature Channel: Diabetes

Voce tem hipotiroidismo? Especialista explica o diagnostico e o que isso significa

Do You Have Hypothyroidism? Expert Explains Diagnosis, What It Means

?Tiene hipotiroidismo? Experto explica el diagnostico y lo que significa

هل أنت مصاب بقصور الدرقية؟ يشرح الخبراء التشخيص وما يعنيه

Online Tool Tests How Taxes Affect Sugar-Sweetened Drink Purchases

Nudge Boosts Statin-Prescribing, Means Fewer Pharmacy Trips

Medicaid Enrollees with Diabetes Lack Access to Medications with Cardiovascular Health Benefits

Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome

Studying Interventions to Help Type 2 Diabetes Patients Avoid Hospitalizations

More Adults Now Use Tirzepatide and Semaglutide Over Conventional Glucose and Weight Lowering Medications

Neonatal Diabetes Model Provides Insights on How Condition Develops

Einstein Research Leads to Designation of New Type of Diabetes

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Switching to Tirzepatide Rather Than Increasing Dulaglutide Dose Leads to Better Glucose Control and More Weight Loss in Patients with Inadequately Controlled Diabetes

ACP and Annals of Internal Medicine Present Breaking Scientific �������� at ACP's Internal Medicine Meeting 2025

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry

Antibiotics Exposure in Infancy May Boost Diabetes Risk

Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

�� Feature Channel: Diabetes

ACP and Annals of Internal Medicine Present Breaking Scientific �� at ACP's Internal Medicine Meeting 2025